The extracorporeal life support program is a multidisciplinary effort to improve organ function in critical cases, such as pulmonary hypertension or cardiac failure, while surgeons work to treat the underlying medical conditions that cause these illnesses.
A large and growing population of patients are supported each year, with an overall survival rate of 75 percent, and a greater than 90 percent survival for neonates with respiratory failure.
The program benefits from the collaboration and expertise of dedicated ECMO specialists, as well as pediatric surgeons, pediatric cardiac surgeons, pediatric cardiologists, perfusionists, respiratory therapists and intensive care specialists in the NICU and PICU. Our pediatric ECMO program was recently recognized for excellence in ECMO care, with a Gold Level ELSO Award for Excellence in Life Support.
We offer extracorporeal life support to children of all ages as well as adults, for both respiratory and cardiac failure, using the most advanced technologies. Our center can provide both venovenous (V-V) and venoarterial (V-A) approaches, ensuring that each patient will receive the possible care.